Contribution: Industrial Research Assistance Program – Contributions to Firms
TARGA BIOMÉDICALE INC. / TARGA BIOMEDICAL INC.
$217,500.00
Accelerating Manufacturing Quality and Clinical Performance of Cell Therapies
FY 2021-22 · 2021-05-10
Summary
The firm will manufacture its cell conditioning product and use it to develop proof-of-concept (PoC) studies for its clients. Success of this objective will lead to R&D contracts and licensing agreements between parties.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Montreal|Montréal, Quebec, Canada
Recipient Type
For-profit organization
Business Number
775533284
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-05-10 | 2021-22 | $190,000.00 |
| 4 | 2021-05-10 | 2021-22 | $190,000.00 |
| 5 | 2021-05-10 | 2021-22 | $217,500.00 |
| 6 | 2021-05-10 | 2021-22 | $217,500.00 |
| 7 | 2021-05-10 | 2021-22 | $217,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 60 jours.
Agreement End Date
2024-03-31
Agreement Number
972290
Agreement Start Date
2021-05-10
Agreement Title
Accelerating Manufacturing Quality and Clinical Performance of Cell Therapies
Agreement Title (French)
Accélérer la qualité de fabrication et les performances cliniques des thérapies cellulaires
Agreement Type
Contribution
Agreement Value
$217,500.00
Amendment Date
2024-01-09
Amendment Number
7
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The firm will manufacture its cell conditioning product and use it to develop proof-of-concept (PoC) studies for its clients. Success of this objective will lead to R&D contracts and licensing agreements between parties.
Description (French)
L'entreprise fabriquera son produit de conditionnement cellulaire et l'utilisera pour réaliser des études de preuve de concept (PoC) pour ses clients. La réussite de cet objectif conduira à des contrats de R-D et à des accords de licence entre les parties.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Saint-Laurent
Federal Riding (French)
Saint-Laurent
Federal Riding Number
24068
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
775533284
Recipient City
Montreal|Montréal
Recipient Country
CA
Recipient Legal Name
TARGA BIOMÉDICALE INC. / TARGA BIOMEDICAL INC.
Recipient Postal Code
H4S 1Z9
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2021-2022-Q1-972290
